The limit of detection results of the reviewed biosensors suggests that molecular imprinting technology can be successfully applied to detect biomarkers of inflammation: HSA, IL-6, IL-1β, IL-2, biomarkers of viral infections: HIV-gp41, HIV-gp120, Dengue-NS1, SARS-CoV-2 antigen, SARS-CoV-2 spike protein, SARS-CoV-2 nucleocapsid protein, C-reactive protein, Hepatitis C virus core antigen and E2 protein, and biomarkers of nosocomial infections: K. pneumoniae, P. aeruginosa, L. monocytogenes, and A. baumanii. The gene discussed is UBE2B; the disease is nosocomial infection.